Zhengbin Yao

Insider Reports History

Location
Houston, TX
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Zhengbin Yao
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zhengbin Yao:

Company Role Class Num Shares Value Price $ Report Date Ownership
ArriVent BioPharma, Inc. President and CEO, Director Stock Option (right to buy) 550,000 02 Feb 2026 Direct
ALUMIS INC. Director Stock Option (Right to Buy) 49,800 30 Jul 2025 Direct
NexImmune, Inc. Director Stock Option (right to buy) 44,983 05 Jul 2023 Direct

Insider Reports Filed by Zhengbin Yao

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVBP ArriVent BioPharma, Inc. 02 Feb 2026 1 $0 4 President and CEO, Director 04 Feb 2026, 20:40
ALMS ALUMIS INC. 30 Jul 2025 1 $0 4 Director 01 Aug 2025, 16:05
AVBP ArriVent BioPharma, Inc. 03 Feb 2025 1 $0 4 President and CEO, Director 14 Feb 2025, 16:27
ALMS ALUMIS INC. 27 Jun 2024 7 $0 4 Director 01 Jul 2024, 16:42
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Director 27 Jun 2024, 16:11
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 President and CEO, Director 25 Jan 2024, 20:39
/report/000095017023032252-yao-zhengbin-2023-07-05 NexImmune, Inc. 05 Jul 2023 1 $0 4 Director 07 Jul 2023, 16:20
/report/000120919123023684-yao-zhengbin-2023-04-04 NexImmune, Inc. 04 Apr 2023 6 $0 4 Director 06 Apr 2023, 20:37
/report/000120919122037006-yao-zhengbin-2022-06-13 NexImmune, Inc. 13 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:57